These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1731803)

  • 1. Antileishmanial activity of hamycin: a polyene antibiotic.
    Sarkar S; Mukherjee T; Patra P; Bhaduri A
    Biochem Biophys Res Commun; 1992 Jan; 182(1):86-91. PubMed ID: 1731803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of amphotericin B on Leishmania donovani promastigotes.
    Saha AK; Mukherjee T; Bhaduri A
    Mol Biochem Parasitol; 1986 Jun; 19(3):195-200. PubMed ID: 3736592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered transport properties of pentamidine-resistant Leishmania donovani and L. amazonensis promastigotes.
    Basselin M; Lawrence F; Robert-Gero M
    Parasitol Res; 1997; 83(5):413-8. PubMed ID: 9197387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of clofazimine, niclosamide & amphotericin B, on electron transport of Leishmania donovani promastigotes.
    Datta G; Bera T
    Indian J Med Res; 2000 Jul; 112():15-20. PubMed ID: 11006656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between inhibition of growth and arginine transport of Leishmania donovani promastigotes in vitro by diamidines.
    Kandpal M; Tekwani BL; Chauhan PM; Bhaduri AP
    Life Sci; 1996; 59(7):PL75-80. PubMed ID: 8761349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani.
    Mukherjee A; Padmanabhan PK; Sahani MH; Barrett MP; Madhubala R
    Mol Biochem Parasitol; 2006 Jan; 145(1):1-10. PubMed ID: 16219371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD; Saha B; Chattopadhyay A
    Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of monoamidoxime derivatives: toward new antileishmanial compounds.
    Paloque L; Bouhlel A; Curti C; Dumètre A; Verhaeghe P; Azas N; Vanelle P
    Eur J Med Chem; 2011 Jul; 46(7):2984-91. PubMed ID: 21555166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhizic acid attenuates growth of Leishmania donovani by depleting ergosterol levels.
    Dinesh N; Neelagiri S; Kumar V; Singh S
    Exp Parasitol; 2017 May; 176():21-29. PubMed ID: 28242356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.
    Mbongo N; Loiseau PM; Billion MA; Robert-Gero M
    Antimicrob Agents Chemother; 1998 Feb; 42(2):352-7. PubMed ID: 9527785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India.
    Singh SK; Bimal S; Narayan S; Jee C; Bimal D; Das P; Bimal R
    Exp Parasitol; 2011 Feb; 127(2):552-8. PubMed ID: 21070771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial activity of polycyclic derivatives.
    Sarciron ME; Terreux R; Prieto Y; Cortes M; Cuellar MA; Tapia RA; Domard M; Walchshofer N; Pétavy AF
    Parasite; 2005 Sep; 12(3):251-8. PubMed ID: 16218213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes.
    Muniaraj M; Sinha PK; Das P
    Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
    Ganguly S; Bandyopadhyay S; Sarkar A; Chatterjee M
    J Microbiol Methods; 2006 Jul; 66(1):79-86. PubMed ID: 16316700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mianserin, an antidepressant kills Leishmania donovani by depleting ergosterol levels.
    Dinesh N; Kaur PK; Swamy KK; Singh S
    Exp Parasitol; 2014 Sep; 144():84-90. PubMed ID: 24950381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity and mode of action of phenolic compounds on Leishmania donovani.
    Antwi CA; Amisigo CM; Adjimani JP; Gwira TM
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007206. PubMed ID: 30802252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.
    Ménez C; Buyse M; Besnard M; Farinotti R; Loiseau PM; Barratt G
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3793-800. PubMed ID: 16966395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A defined medium for Leishmania culture allows definition of essential amino acids.
    Nayak A; Akpunarlieva S; Barrett M; Burchmore R
    Exp Parasitol; 2018 Feb; 185():39-52. PubMed ID: 29326050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188.
    Espuelas S; Legrand P; Loiseau PM; Bories C; Barratt G; Irache JM
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2190-2. PubMed ID: 10898700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro 'time-to-kill' assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum.
    Maes L; Beyers J; Mondelaers A; Van den Kerkhof M; Eberhardt E; Caljon G; Hendrickx S
    J Antimicrob Chemother; 2017 Feb; 72(2):428-430. PubMed ID: 27707992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.